Division of Population Medicine, Cardiff University, Cardiff, UK.
Division of Population Medicine, Cardiff University, Cardiff, UK; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London,UK.
Patient Educ Couns. 2017 Aug;100(8):1572-1579. doi: 10.1016/j.pec.2017.02.024. Epub 2017 Feb 27.
This study aimed to examine the relationship between pre-screening expectations and psychological responses to low-dose computerised tomography (LDCT) screening among high-risk individuals in the United Kingdom Lung Cancer Screening (UKLS) pilot trial.
Prior to screening, high-risk individuals randomised into the intervention arm of the UKLS were asked about their expected screening test result. Their actual LDCT scan result was compared with their baseline screening expectation to determine the level of congruence. Levels of concern about and perceived accuracy of the result were assessed in a questionnaire two weeks following receipt of their test result.
The sample included 1589 participants. Regardless of their expected results, patients who required follow-up investigations after their initial LDCT scan were the most concerned about their result (p<0.001). Participants who expected to require follow-up, but did not need it, perceived the test to be least accurate (p=0.006).
Lung cancer screening participants who require follow-up or who have unexpected negative results can be identified for supportive interventions.
These findings can be used to ensure that any future LDCT lung cancer screening programme is tailored to identify and support those high-risk individuals who may benefit from additional help.
本研究旨在探讨英国肺癌筛查(UKLS)试验中高危人群在接受低剂量计算机断层扫描(LDCT)筛查前的预期与心理反应之间的关系。
在筛查前,随机分配到 UKLS 干预组的高危个体被问及他们预期的筛查测试结果。将他们的实际 LDCT 扫描结果与基线筛查预期进行比较,以确定一致性水平。在收到测试结果两周后,通过问卷调查评估对结果的关注程度和感知准确性。
该样本包括 1589 名参与者。无论他们的预期结果如何,在初始 LDCT 扫描后需要进行随访调查的患者对其结果最为关注(p<0.001)。那些预期需要随访但实际上不需要的参与者认为该测试准确性最低(p=0.006)。
可以对需要随访或出现意外阴性结果的肺癌筛查参与者进行识别并提供支持性干预。
这些发现可用于确保未来的 LDCT 肺癌筛查计划能够根据需要确定和支持那些可能受益于额外帮助的高危个体。